The Latest
The WasteWatcherFederal Funding for Broadband Should Be Vendor and Technology Neutral
When planning infrastructure spending on broadband deployment, rules should be technology and vendor neutral.
The WasteWatcherPrice Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The WasteWatcherOnly Taxpayers Know What They Owe and the IRS Should Never File Anyone’s Taxes
Sen. Warren's proposal would vastly expand the size and scope of the IRS’s power.
Op-EdsSpectrum auction authority must be extended
To achieve the socio-economic benefits that 5G and other new technologies will bring, the FCC must be enabled to create a balanced spectrum pipeline.
Op-EdsStudent loan forgiveness is regressive and inflationary
Student loan forgiveness will not only waste taxpayers’ money but also drive inflation even higher.
The WasteWatcherThe Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The WasteWatcherThe Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Agency CommentsCAGW Signs Letter on Pole Attachments
VIA ECFS Ms. Marlene H. Dortch Secretary Federal Communications Commission 45 L Street, NE Washington, D.C. 20554
The WasteWatcherLimiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
Press ReleaseCitizens Against Government Waste Names Education Secretary Miguel Cardona June 2022 Porker of the Month
Education Secretary Miguel Cardona is trying to force taxpayers to bailout student loan borrowers.
The WasteWatcherGAO Report Reveals Significant Duplication and Overlap in Broadband Programs
A recent report from the Government Accountability Office lays out paths to reduce wasteful practices in broadband programs.
The WasteWatcherRegulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
